Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What is the current market size of the alopecia treatment industry, and what growth rate is it expected to achieve?
The alopecia treatment market size has grown strongly in recent years. It will grow from $9.56 billion in 2024 to $10.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing prevalence of alopecia, aging population, hormonal changes, genetic predisposition, rising awareness about hair loss treatments, growth in cosmetic and dermatology industries and improved healthcare access.
The alopecia treatment market size is expected to see strong growth in the next few years. It will grow to $13.22 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing adoption of non-invasive treatments, growing demand for personalized medicine, increasing focus on mental health and self-esteem, rising consumer awareness about hair loss causes and treatments and increasing clinical trials for alopecia therapies. Major trends in the forecast period include the advancement of stem cell-based hair regeneration, use of platelet-rich plasma (PRP) therapy, development of jake inhibitors for autoimmune alopecia, innovations in laser hair therapy, and wearable devices for hair growth stimulation.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24140&type=smp
What are the major drivers contributing to the growth of the alopecia treatment market?
The increasing prevalence of hair loss is expected to propel the growth of the alopecia treatment market going forward. Hair loss refers to the condition where an individual experiences the partial or complete loss of hair from the scalp or other parts of the body. The prevalence of hair loss is increasing due to rising stress levels, which can disrupt the normal hair growth cycle and trigger conditions such as telogen effluvium, leading to excessive hair shedding. As more individuals seek effective solutions to manage and reverse hair loss, the demand for advanced and accessible alopecia treatments is rising. For instance, in October 2024, according to the American Academy of Dermatology, a US-based professional medical association focused on dermatology, 80 million Americans were affected by hair loss, including 50 million men and 30 million women. Therefore, the increasing prevalence of hair loss is driving the growth of the alopecia treatment market.
What are the major market segments driving the growth of the alopecia treatment industry?
The alopecia treatment market covered in this report is segmented –
1) By Dosage Form: Drug Therapy, Hair Transplant Services, Low-Level Laser Therapy
2) By Route of Administration: Topical, Injectable, Oral
3) By Indication: Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Alopecia Barbae, Chemotherapy Induced Alopecia, Other Indications
4) By Gender Type: Male, Female
5) By End User: Hospitals And Physicians Offices, Dermatology Clinics, Other End Users
Subsegments:
1) By Drug Therapy: Topical Solutions, Oral Medications, Injectable Treatments, Immunosuppressants, Janus Kinase Inhibitors
2) By Hair Transplant Services: Follicular Unit Transplantation (FUT), Follicular Unit Extraction (FUE), Robotic Hair Transplantation, Direct Hair Implantation (DHI)
3) By Low-Level Laser Therapy (LLLT): Laser Helmets, Laser Combs, Laser Caps, In-Clinic Laser Devices
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/alopecia-treatment-global-market-report
What are the key trends shaping the alopecia treatment market in the forecast period?
Major companies operating in the alopecia treatment market are focusing on developing innovative solutions such as oral small-molecule kanus kinase (JAK) inhibitors to enhance treatment efficacy, accelerate hair regrowth, and offer targeted therapy for patients with severe or resistant forms of alopecia areata. Oral small-molecule janus kinase (JAK) inhibitors are a class of targeted pharmaceutical drugs designed to block the activity of one or more of the Janus kinase enzymes (JAK1, JAK2, JAK3, and TYK2). For instance, in July 2024, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, received a US Food and Drug Administration (FDA) approval for LEQSELVI, an oral Janus kinase (JAK) inhibitor, for the treatment of adults with severe alopecia areata. It is a selective inhibitor of JAK1 and JAK2 enzymes, which are involved in the immune system’s attack on hair follicles in this autoimmune disorder. The recommended dosage is 8 mg orally twice daily, with or without food. This approval of LEQSELVI offers a new, effective treatment option for individuals suffering from this condition, which can have profound physical, emotional, and social impacts.
Who are the key market players contributing to the growth of the alopecia treatment industry?
Major companies operating in the alopecia treatment market are Pfizer Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Inc., Incyte Corporation, Hims & Hers Health Inc., Bosley Inc., Hair Club Co., Dermavant Sciences Inc., Histogen Inc., Capillus llc, Aclaris Therapeutics Inc., Nutrafol, Alvi Armani Co, Rogaine, Theradome Inc., Viviscal Ltd, Arena Pharmaceuticals Ltd, Cassiopea SA, Follica Inc., RepliCel Life Sciences Inc., HairClone Ltd, Revian Inc., Nioxin.
Which regions are leading the growth of the alopecia treatment market globally?
North America was the largest region in the alopecia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alopecia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Alopecia Treatment Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24140&type=smp
Need Customized Data On Alopecia Treatment Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24140&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
